Suchergebnisse - "Kantaridis, Constantino"

PubPharm (13)

1

A Phase 1 first-in-human study of the safety, tolerability, and pharmacokinetics of the ROBO2 fusion protein PF-06730512 in healthy participants

enthalten in: Pharmacology research & perspectives | 2021

von Lim, C. | Kantaridis, C. | Huyghe, I. | +3

2

A Phase 1 first‐in‐human study of the safety, tolerability, and pharmacokinetics of the ROBO2 fusion protein PF‐06730512 in healthy participants

enthalten in: Pharmacology Research & Perspectives | 2021

von Lim, C. | Kantaridis, C. | Huyghe, I. | +3

3

A mechanistic pharmacokinetic model with drug and antidrug antibody interplay, and its application for assessing the impact of immunogenicity response on bioequivalence testing

enthalten in: British journal of clinical pharmacology | 2020

von Liao, K. | Udata, C. | Yin, D. | +4

4

Pharmacokinetic and Pharmacodynamic Effects of a γ-Secretase Modulator, PF-06648671, on CSF Amyloid-β Peptides in Randomized Phase I Studies

enthalten in: Clinical pharmacology and therapeutics | 2020

von Ahn, J. | Carrieri, C. | Dela Cruz, F. | +9

5

A mechanistic pharmacokinetic model with drug and antidrug antibody interplay, and its application for assessing the impact of immunogenicity response on bioequivalence testing

enthalten in: British Journal of Clinical Pharmacology | 2020

von Liao, K. | Udata, C. | Yin, D. | +4

6

Pharmacokinetic and Pharmacodynamic Effects of a γ‐Secretase Modulator, PF‐06648671, on CSF Amyloid‐β Peptides in Randomized Phase I Studies

enthalten in: Clinical Pharmacology & Therapeutics | 2020

von Ahn, J. | Carrieri, C. | Dela Cruz, F. | +9

7

Evaluation of crizotinib absolute bioavailability, the bioequivalence of three oral formulations, and the effect of food on crizotinib pharmacokinetics in healthy subjects

enthalten in: Journal of clinical pharmacology | 2015

von Xu, H. | O'Gorman, M. | Boutros, T. | +4

8

The effects of boceprevir and telaprevir on the pharmacokinetics of maraviroc : an open-label, fixed-sequence study in healthy volunteers

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2014

von Vourvahis, M. | Plotka, A. | Kantaridis, C. | +2

9

OPEN - The Effects of Boceprevir and Telaprevir on the Pharmacokinetics of Maraviroc: An Open-Label, Fixed-Sequence Study in Healthy Volunteers

enthalten in: Journal of acquired immune deficiency syndromes | 2014

von Vourvahis, M. | Plotka, A. | Kantaridis, C. | +2

10

Antiviral activity of the hepatitis C virus polymerase inhibitor filibuvir in genotype 1-infected patients

enthalten in: Hepatology (Baltimore, Md.) | 2011

von Wagner, F. | Thompson, R. | Kantaridis, C. | +6